Anti APOC3 mAb (Clone 8H12)

Catalog No:
CSB-RA925915A0HU-50
$210.00
Application: IHC, ELISA 
Clonality: Monoclonal 
Purification: Purified - Affinity 
Reactivity: Human 
Component of triglyceride-rich very low density lipoproteins (VLDL) and high density lipoproteins (HDL) in plasma (PubMed:18201179, PubMed:22510806). Plays a multifaceted role in triglyceride homeostasis (PubMed:18201179, PubMed:22510806). Intracellularly, promotes hepatic very low density lipoprotein 1 (VLDL1) assembly and secretion; extracellularly, attenuates hydrolysis and clearance of triglyceride-rich lipoproteins (TRLs) (PubMed:18201179, PubMed:22510806). Impairs the lipolysis of TRLs by inhibiting lipoprotein lipase and the hepatic uptake of TRLs by remnant receptors (PubMed:18201179, PubMed:22510806). Formed of several curved helices connected via semiflexible hinges, so that it can wrap tightly around the curved micelle surface and easily adapt to the different diameters of its natural binding partners (PubMed:18408013).
Documents & Links for Anti APOC3 mAb (Clone 8H12)
DatasheetAnti APOC3 mAb (Clone 8H12) Datasheet
Vendor PageAnti APOC3 mAb (Clone 8H12) at CUSABIO

Documents & Links for Anti APOC3 mAb (Clone 8H12)
DatasheetAnti APOC3 mAb (Clone 8H12) Datasheet
Vendor PageAnti APOC3 mAb (Clone 8H12)